7,585.25

+10.75

+0.14%

51,984.00

-149.00

-0.29%

28,318.25

+190.75

+0.68%

Russell 2000 Futures

2,830.80

+13.00

+0.46%

4.9120

+0.0180

+0.37%

20.87

-0.28

-1.32%

3,970.50

+0.90

+0.02%

77,108.58

-639.32

-0.82%

Crude Oil Dec 26

94.58

-1.88

-1.95%

US Private Equity

10,836.30

-14.33

-0.13%

NasdaqCM - Nasdaq Real Time Price USD

Solesence, Inc. (SLSN)

0.8560 +0.0059 (+0.69%)

At close: November 2 at 4:00:01 PM EST

Loading Chart for SLSN

Chart Range Bar

Interval:

In partnership with ChartIQ

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...

Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...

Solésence Reports Second Quarter 2026 Financial Results

Solésence Reports Second Quarter 2026 Financial Results

Solésence Reschedules Second Quarter 2026 Conference Call to August 19

Solésence Reschedules Second Quarter 2026 Conference Call to August 19

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

SLSN Unveils Two Scalp Care Products Using Patented Technology

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Zacks Initiates Coverage of SLSN With Underperform Recommendation

Solesence, Inc. Common Stock Q4 2025 Earnings Call Summary

Solesence, Inc. Common Stock Q4 2025 Earnings Call Summary

Mobilize your Website

View Site in Mobile | Classic

Share by: